Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone
- 27 April 2001
- Vol. 28 (4) , 370-377
- https://doi.org/10.1016/s8756-3282(01)00404-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The Role of Receptor Activator of Nuclear Factor- B Ligand and Osteoprotegerin in the Pathogenesis and Treatment of Metabolic Bone DiseasesJournal of Clinical Endocrinology & Metabolism, 2000
- Expression of Osteoclast Differentiation Signals by Stromal Elements of Giant Cell TumorsJournal of Bone and Mineral Research, 2000
- Expression of functional RANK on mature rat and human osteoclastsFEBS Letters, 1999
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999
- Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursorsJournal of Cellular Biochemistry, 1999
- RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in OsteoclastogenesisBiochemical and Biophysical Research Communications, 1998
- Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell CulturesBiochemical and Biophysical Research Communications, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Parathyroid Hormone-Related Protein in Hypercalcemia Associated with Hematological MalignancyLeukemia & Lymphoma, 1998
- Purification and characterization of fully functional human osteoclast precursorsJournal of Bone and Mineral Research, 1996